Synergy of losartan and chemotherapy for patients with cholangiocarcinoma: a propensity score-matched analysis

HIGHLIGHTS

  • who: Qing Li from the University of California, Los Angeles, United States have published the research: Synergy of Losartan and chemotherapy for patients with cholangiocarcinoma: A propensity score-matched analysis, in the Journal: (JOURNAL) of December/30,/2019
  • what: The authors aimed to compare the survival outcomes related with the effect of losartan in patients CCA after surgery. The study was approved by the Ethics Committee of the Institutional Review Board of the Department of General frontiersin.org 10.3389/fonc.2022.989080 and tumor suppressor genes; 2) genes that are targets of agents approved . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?